Regen Med

United States
Quinlan, Texas, United States, 06830

Company profile

Regen Med company profile

“Regenerative medicine” is about how cells, factors, proteins, tissues and other basic elements of the body work together to promote health, function and longevity. Regen Med is about how hospitals, scientists, individual clinicians, medical societies, payors and regulators collaborate to exploit for the benefit of patients — in an evidence-based manner — this broad, exciting field. At the core of Regen Med’s mission are two, mutually-supporting pillars: inCytes™ and Human/Cell Tissue Centers. These provide the foundation for cost-efficient delivery of evidence-based, regulatorily compliant regenerative medicine procedures (whether primary or adjunct). That same foundation also supports studies, trials, product incubation, value-based medicine, improved patient experience, professional education and clinical growth. Finally, this foundation enables deep, ongoing and professionally-rewarding collaboration among Regen Med Network members around the world.”

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
06830
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$290,000
Last funding
Seed / $290,000 / 2025-02-18
Last equity funding
Seed / $290,000
Articles
1

Founders and investors

No public relation records are available.